New Oncology Partnership Charting The Future For Cancer Care
West Cancer Center is partnering with Tennessee Oncology and New York Cancer and Blood Specialists to form OneOncology. This collaboration will strengthen community cancer centers across the country and provide even greater access to new cancer treatment protocols, the latest clinical trials and cutting edge-research, right at home.
MEMPHIS, Tenn., Sept. 14, 2018 /PRNewswire-PRWeb/ -- West Cancer Center is evolving into a new model in its next chapter as a patient-centric, physician-driven and technology-powered center with a mission to improve the lives of those living with and beyond cancer, officials announced today.
Building upon its 40-year legacy of innovation, West Cancer Center is affiliating with a new national partner that is solely dedicated to community cancer care. This enables West Cancer Center to retain its singular focus on making physician-driven decisions to do what is best for patients, the community and the future of adult cancer care in Memphis and the Mid-South. West Cancer Center will be working with a new national partner-OneOncology-beginning January 2019 and will allow West to continue pursuing National Cancer Institute (NCI) designation and investing resources in Academic and Research Programs both locally and nationally
"We're excited to join the dynamic new model at OneOncology," said Dr. Lee Schwartzberg, West Cancer Center's executive director. "Today's challenging and complex healthcare landscape requires that we build new solutions that advance our mission to provide dedicated, clinical excellence with a focus on the latest, most innovative personalized treatment plans. This is a natural next chapter for us and maintains patients at the center of all that we do."
The national organization is a partnership of oncologists and leading industry experts bringing together the best of oncology, technology and finance to strengthen cancer care and mitigate challenges facing community oncology centers. West Cancer Center patients will benefit from even greater access to new treatment protocols, the latest clinical trials and cutting-edge research.
Methodist LeBonheur Healthcare (MLH) and West Cancer Center will conclude their formal partnership at the end of 2018 with each organization planning for a new model that will benefit patients in this community. Both MLH and West Cancer Center have been deeply committed to their shared goal of providing the most innovative healthcare options and building a superior, innovative, research-driven adult cancer center over the past seven years.
"We're proud of our accomplishments together," Schwartzberg said. "Know that our existing and future patients will continue to experience seamless access to the same level of excellent adult cancer care."
In the new partnership, West Cancer Center will be empowered to better support the entire continuum of care, including prevention and diagnosis, research and treatment, long-term survivorship and palliative and hospice care. Through this comprehensive approach, West Cancer Center aims to always improve the patient experience and outcomes.
Schwartzberg said the new partnership will enable the nation's best oncologists to learn from unique challenges, drive meaningful innovation and leverage the benefits for patients. West Cancer Center joins two like-minded community cancer centers -- New York Cancer & Blood Specialists and Tennessee Oncology – as the three founding practices of the national organization. Together, they will have more than 225 oncology providers, more than 60 care locations and treat nearly 158,000 patients per year.
Media Contact:
Julie Flanery, Director/Marketing Communications and Business Development
[email protected]
About West Cancer Center
West Cancer Center is multi-specialty, academic, regional cancer center specializing in adult cancer and blood disorder treatment, research and prevention. Over 37,000 patients were treated across our 13 locations in 2017. Our faculty diligently trains the next generation of cancer experts, including over 20 fellows and residents exclusively focused on advanced oncology education.
Our commitment to translate cancer science into revolutionary treatment protocols is furthered by the enrollment of 500 patients in clinical trials for 2017 and 4,210 analytic cases recorded to the tumor registry annually. West Cancer Center's focus on genomic testing and precision medicine, subspecialty care, translational research and new clinical pathways provide patients with the latest, most innovative, personalized cancer treatment plans. Our dedication to clinical excellence extends beyond conventional care with programs and services that focus on the mind, body and spirit to improve overall wellness and outcomes. For more information, visit westcancercenter.org and follow us on Facebook, Twitter, YouTube and Instagram.
About OneOncology
OneOncology, a partnership of independent community oncology practices and finance and technology experts, is positioning community oncologists to drive the future of cancer care through a patient-centric, physician-driven, and technology-powered model to help improve the lives of everyone living with cancer. Visit http://www.oneoncology.com or follow us on Twitter @oneoncology and LinkedIn.
SOURCE West Cancer Center
Share this article